Advertisement

Topics

Myriad Genetics announces new data on EndoPredict test at 2017 San Antonio Breast Cancer Symposium

03:15 EST 12 Dec 2017 | News-Medical.net

Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced new results from two studies with EndoPredict are being featured at the 2017 San Antonio Breast Cancer Symposium in San Antonio, Texas.

Original Article: Myriad Genetics announces new data on EndoPredict test at 2017 San Antonio Breast Cancer Symposium

NEXT ARTICLE

More From BioPortfolio on "Myriad Genetics announces new data on EndoPredict test at 2017 San Antonio Breast Cancer Symposium"

Quick Search
Advertisement
 

Relevant Topics

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...